Literature DB >> 19252767

Rhabdomyolysis caused by co-medication with simvastatin and clarithromycin.

Judith Wagner, Christine Suessmair, Hans-Walter Pfister.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19252767     DOI: 10.1007/s00415-009-5078-6

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  8 in total

1.  Rhabdomyolysis associated with concomitant use of simvastatin and clarithromycin.

Authors:  A Juhani Kahri; Miia M Valkonen; Matti K E Vuoristo; Pertti J Pentikäinen
Journal:  Ann Pharmacother       Date:  2004-02-13       Impact factor: 3.154

2.  Rhabdomyolysis resulting from interaction of simvastatin and clarithromycin demonstrated by Tc-99m MDP scintigraphy.

Authors:  Joseph Trieu; Louise Emmett; Chandi Perera; Krish Thanakrishnan; Hans Van Der Wall
Journal:  Clin Nucl Med       Date:  2004-12       Impact factor: 7.794

3.  Proposal for a new tool to evaluate drug interaction cases.

Authors:  John R Horn; Philip D Hansten; Lingtak-Neander Chan
Journal:  Ann Pharmacother       Date:  2007-03-27       Impact factor: 3.154

Review 4.  Statins for the prevention of first or recurrent stroke.

Authors:  Vasilios G Athyros; Anna I Kakafika; Konstantinos Tziomalos; Athanassios A Papageorgiou; Asterios Karagiannis
Journal:  Curr Vasc Pharmacol       Date:  2008-04       Impact factor: 2.719

Review 5.  Management of dyslipidemia in the high-risk patient.

Authors:  Evan A Stein
Journal:  Am Heart J       Date:  2002-12       Impact factor: 4.749

Review 6.  Rhabdomyolysis secondary to a drug interaction between simvastatin and clarithromycin.

Authors:  A J Lee; D S Maddix
Journal:  Ann Pharmacother       Date:  2001-01       Impact factor: 3.154

7.  Simvastatin-associated rhabdomyolysis after coadministration of macrolide antibiotics in two patients.

Authors:  Espen Molden; Kirsti Svendsen Andersson
Journal:  Pharmacotherapy       Date:  2007-04       Impact factor: 4.705

8.  Does statin therapy initiation increase the risk for myopathy? An observational study of 32,225 diabetic and nondiabetic patients.

Authors:  Gregory A Nichols; Carol E Koro
Journal:  Clin Ther       Date:  2007-08       Impact factor: 3.393

  8 in total
  7 in total

1.  Clarithromycin-induced rhabdomyolysis: a case report.

Authors:  Giuseppe Pasqualetti; Giacomo Bini; Sara Tognini; Antonio Polini; Fabio Monzani
Journal:  Int J Gen Med       Date:  2012-03-20

2.  Acute rhabdomyolysis associated with coadministration of levofloxacin and simvastatin in a patient with normal renal function.

Authors:  Maria Paparoupa; Sebastian Pietrzak; Adrian Gillissen
Journal:  Case Rep Med       Date:  2014-07-22

3.  Statin-induced rhabdomyolysis: a complication of a commonly overlooked drug interaction.

Authors:  Saad Ezad; Hooria Cheema; Nicholas Collins
Journal:  Oxf Med Case Reports       Date:  2018-03-14

4.  Trends and variations in outpatient coprescribing of simvastatin or atorvastatin with potentially interacting drugs in Thailand.

Authors:  Thananan Rattanachotphanit; Chulaporn Limwattananon; Onanong Waleekhachonloet
Journal:  Ther Adv Drug Saf       Date:  2019-01-30

5.  The clinical significance of statins-macrolides interaction: comprehensive review of in vivo studies, case reports, and population studies.

Authors:  Abdallah Abu Mellal; Nadia Hussain; Amira Sa Said
Journal:  Ther Clin Risk Manag       Date:  2019-07-23       Impact factor: 2.423

6.  Letter in response to the article: Pros and cons for use of statins in 59 people with coronavirus disease-19 (COVID-19)(Ray, S et al.).

Authors:  Tie Zhao; Liang Peng
Journal:  Diabetes Metab Syndr       Date:  2020-11-25

7.  A population-based analysis of the risk of drug interaction between clarithromycin and statins for hospitalisation or death.

Authors:  Bita Mesgarpour; Ghazaleh Gouya; Harald Herkner; Berthold Reichardt; Michael Wolzt
Journal:  Lipids Health Dis       Date:  2015-10-24       Impact factor: 3.876

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.